Abrocitinib Related Compound 2
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Abrocitinib Related Compound 2

● Under Development

Catalogue No.:VL5020003
CAS No.:N/A
Mol. Formula:C19H21N5O2
Mol. Weight:351.41 g/mol

Additional information on Abrocitinib Related Compound 2

Parent drug

Abrocitinib

IUPAC Name

benzyl ((1s, 3s)-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)cyclobutyl)carbamate

Synonyms

N/A

Description

Abrocitinib Related Compound 2 or benzyl ((1s,3s)-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)carbamate, is a Janus kinase 1 (JAK1) selective inhibitor, Immunosuppressive agents and used in the treatment of atopic dermatitis (eczema).

References

Kim, Hyeon, et al. “Pharmacokinetic Properties of Acetyl Tributyl Citrate, a Pharmaceutical Excipient.” Pharmaceutics, vol. 10, no. 4, 8 Oct. 2018, p. 177, 10.3390/pharmaceutics10040177.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form